In focus · trending topic

Bristol Myers Squibb

2 stories · following the connections

Tempus Sets $55 Million Ceiling for Pathos Neurology Data Contract

By Helena WardOct 24, 2026, 2:47 PM UTC

INVESTORS SAY EXECUTIVE PAY PACKAGES AT PHARMA MAY INCENTIVIZE DRUG PRICING RISKS

By Nasdaq OMXDec 13, 2017, 6:13 PM UTC